1. Home
  2. OGI vs ENTX Comparison

OGI vs ENTX Comparison

Compare OGI & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

N/A

Current Price

$0.88

Market Cap

133.5M

Sector

Health Care

ML Signal

N/A

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$3.13

Market Cap

147.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OGI
ENTX
Founded
2013
2010
Country
Canada
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.5M
147.4M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
OGI
ENTX
Price
$0.88
$3.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$2.44
★ $9.75
AVG Volume (30 Days)
414.5K
★ 548.6K
Earning Date
12-15-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ 0.22
Revenue
N/A
★ $42,000.00
Revenue This Year
$34.95
N/A
Revenue Next Year
$30.97
N/A
P/E Ratio
★ $13.91
$14.14
Revenue Growth
★ N/A
N/A
52 Week Low
$0.85
$0.91
52 Week High
$2.24
$4.20

Technical Indicators

Market Signals
Indicator
OGI
ENTX
Relative Strength Index (RSI) 36.55 58.75
Support Level N/A $2.64
Resistance Level $0.96 $3.26
Average True Range (ATR) 0.05 0.22
MACD 0.00 0.01
Stochastic Oscillator 11.97 74.00

Price Performance

Historical Comparison
OGI
ENTX

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: